Immune Response News and Research

RSS

Novel strategy to create a genetic vaccine against P. aeruginosa

Pseudomonas aeruginosa is a bacterium that can cause respiratory tract infections, which can be life threatening in patients who have cystic fibrosis. It is therefore important to develop a vaccine against this pathogen.

3 Apr 2005

Stress may enhance the body's ability to fight the flu

Short bouts of intense social stress improved the ability in the mice to recover from the flu. The stress apparently did so by substantially boosting the production of specialized immune cells that fought the virus.

3 Apr 2005

Smack that bottom - it can cure everything !!

Russian scientists at the Novosibirsk Institute of Medicine are claiming a beating on the naked buttocks with a cane is the perfect way to cure everything from depression to alcoholism.

29 Mar 2005

Vical Incorporated issued two Canadian patents

Vical Incorporated announced today the issuance of two Canadian patents on the company's core technology, which involves direct administration of polynucleotide genetic material such as DNA or RNA.

29 Mar 2005

Cells that might be able to suppres cat allergies

In a paper in this month's premier open-access medical journal PLoS Medicine, Mark Larche and colleagues from Imperial College London describe a subset of cells that might be able to suppress cells that cause cat allergy.

29 Mar 2005

Vital molecular step in cell migration

A vital molecular step in cell migration, the movement of cells within the body during growth, tissue repair and the body's immune response to invading pathogens, has been demonstrated by researchers in the University of California, San Diego (UCSD) School of Medicine.

28 Mar 2005

Genome in gut bacterium key to intestinal health

A bacterium that lives in the human gut adaptively shifts more than a quarter of its genes into high gear when its host's diet changes from sugar to complex carbohydrates.

28 Mar 2005

NIAID investigates safety of H5N1 avian influenza vaccine

Fast-track recruitment has begun for a trial to investigate the safety of a vaccine against H5N1 avian influenza, the National Institute of Allergy and Infectious Diseases (NIAID) announced today.

23 Mar 2005

No serious adverse events found with next-generation smallpox vaccine

Interim data from a phase I/II clinical trial of a next-generation vaccine for smallpox suggest that the vaccine may provide immunity and thus far the trial has been without any serious adverse events.

22 Mar 2005

Structure of key protein in innate immune response

In a report published in the Journal of Biological Chemistry, scientists in Korea announced their elucidation of three-dimensional structure of CD14 and showed how it is perfectly suited to bind to certain bacterial products.

21 Mar 2005

Progress toward development of a breast cancer vaccine

Progress toward development of a breast cancer vaccine has been reported by researchers at Washington University School of Medicine and the Siteman Cancer Center in St. Louis.

8 Mar 2005

Thalidomide may have a new lease of life as a cancer treatment

The drug thalidomide may have a new lease of life as a cancer treatment. A small study published in Gut suggests that it slows down the weight loss and wasting associated with advanced disease in patients with pancreatic cancer.

7 Mar 2005

WHO says countries should stockpile H5N1 vaccine

The World Health Organization is about to advise countries to stockpile the influenza vaccine strain known as H5N1, responsible for the deadly birdflu outbreak in Southeast Asia.

7 Mar 2005

Molecule from South American tree Quillaja, helps battle disease

The first synthesis of QS-21A, a medicinally important molecule that helps the body battle disease, has been achieved by chemists at the University of Illinois at Urbana-Champaign.

1 Mar 2005

OPAL, major discovery in the fight against AIDS

Australian researchers have made a major discovery in the fight against AIDS, with the development of a novel, simple and safe technique for boosting the body’s immune response to deadly viruses like HIV, which is even effective against drug resistant forms of the disease.

1 Mar 2005

VIRxSYS novel HIV gene therapy yields exciting results

VIRxSYS Corporation reports unexpected and unprecedented findings in its ongoing Phase I clinical trial of its VRX496 therapy in patients with HIV.

28 Feb 2005

Fear of botulism as a bioterrorist weapon is to be reduced by British vaccine technology

Fear of botulism as a bioterrorist weapon is to be reduced, as the US government announces its support for a new British vaccine technology, which promises for the first time to provide an effective defence against botulism – the most deadly naturally occurring substance.

28 Feb 2005

People with osteoporosis should be screened for celiac disease

Results of a new study suggest that the higher prevalence of celiac disease in individuals with osteoporosis than in the general population may justify screening of patients with osteoporosis for celiac disease, according to an article in the February 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

28 Feb 2005

New medical devices can cause new immune problems

Medical devices are traditionally thought of as fairly simple implants such as stents and hip replacements – pieces of plastic or metal that are placed in the body to handle a very specific function. But biomedical devices now on the drawing board are considerably more sophisticated and represent an unprecedented melding of man and machine.

28 Feb 2005

Research shows preventive effects of cannabinoids on Alzheimer's disease

New research shows that a synthetic analogue of the active component of marijuana may reduce the inflammation and prevent the mental decline associated with Alzheimer's disease.

22 Feb 2005